Contact
Please use this form to send email to PR contact of this press release:
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
TO:
Please use this form to send email to PR contact of this press release:
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
TO: